B O O K - American College of Rheumatology

monday
Upon completion of this session, participants should be able to:
• discuss the most recent thoughts regarding the
pathophysiology of fibromyalgia and related disorders
• prescribe a treatment program for the typical fibromyalgia
patient and serve as a consultant to that patient and the
primary care provider
• describe the principles of a comprehensive treatment
program for the more challenging fibromyalgia patient
B210
Immunodeficiency Syndromes (024)
Speaker: Alton Melton, MD; Cleveland Clinic; Cleveland, OH
Upon completion of this session, participants should be able to:
• review the immunology and clinical manifestations of the
major immune deficiency syndromes that both adult and
pediatric rheumatologist might encounter
• discuss the diagnostic evaluation for someone suspected of
having an immune deficiency syndrome
• illustrate therapeutic options with cases
B301
Myopathy: Issues in Diagnosis and Treatment (025)
f
Speaker: Mark F. Gourley, MD; NIAMS; Bethesda, MD
Upon completion of this session, participants should be able to:
• distinguish inflammatory myopathies from other muscles
diseases
• plan a diagnostic work-up for a patient with signs and
symptoms of muscle disease
• design a treatment program for a patient with myositis
B304
Rheumatoid Arthritis: Outcome Measures in Clinical
Practice (028) PS
Speaker: Martin J. Bergman, MD; Arthritis and Rheumatology;
Ridley Park, PA
Upon completion of this session, participants should be able to:
• discuss outcome measures used in rheumatoid arthritis
• integrate outcome measures into an office-based practice
B305
Systemic Lupus Erythematosus: Central Nervous
System (029)
Speaker: F. Jorge Sanchez-Guerrero, MD; Instituto Nacional
Nutricion; Mexico City, Mexico
Upon completion of this session, participants should be able to:
• identify manifestations of central nervous system lupus
• select appropriate diagnostic tests in patients with central
nervous system lupus
• formulate a treatment plan
B306
Temporal Arteritis (030)
Speaker: Gene G. Hunder, MD; Mayo Clinic; Rochester, MN
Upon completion of this session, participants should be able to:
• discuss the most current concepts in diagnosis of temporal
arteritis, including the use of imaging modalities
• identify evolving concepts in treatment of temporal arteritis,
including appropriate use of corticosteroids, as well as the
data regarding the efficacy of other “steroid sparing” agents
• describe controversial areas in diagnosis and management of
temporal arteritis
52
B302
Pediatric Systemic Lupus (026) P
Speaker: Ilona S. Szer, MD; Rady Children’s Hospital; San Diego,
CA
Upon completion of this session, participants should be able to:
• discuss differences in presentation, disease course and
treatment options between childhood-onset and adult-onset
systemic lupus erythematosus
• cite recent and ongoing research efforts in childhood-onset
systemic lupus erythematosus
• describe important developmental issues in the care of
children and adolescents with a chronic disease
B303
Psoriatic Arthritis (027)
Speaker: Dafna D. Gladman, MD; Toronto Western Hospital;
Toronto, ON, Canada
Upon completion of this session, participants should be able to:
• discuss advances in diagnosis and classification of psoriatic
arthritis
• determine if patients with psoriatic arthritis should be treated
aggressively
• determine treatment options for patients with psoriatic
arthritis
2010 Program Book
ACR Special Session
4:30 - 6:00 PM
B313
Legislative Update from Capitol Hill
Moderator: Sharad Lakhanpal, MB, MD; University of Texas
Southwestern; Dallas, TX
This session is not eligible for CME credit.
4:30 PM
Health Policy Discussion
Speaker to be announced
Session Overview:
Advocacy is a top priority of the American College of
Rheumatology. Legislative and regulatory actions include
Medicare physician reimbursement, increased research funding
for arthritis or lupus, health care reform, incentives for health
information technology, and directly patients with rheumatic
affect diseases. This session has been designed to provide
rheumatologists and health professionals a forum to discuss
what is on the congressional agenda that could affect them and
their patients.
Upon completion of this session, participants should be able to:
• discuss legislative actions that Congress has taken in the past
year
• explain Congress and the Administration’s role in creating
health policy
• assess health care legislation and its effects on the
rheumatology profession